SCHEMBL31426093

SCHEMBL31426093

CN(C)Cc1n[nH]c2cc(Br)ccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 2/20 0.53
JAK2 O60674 2/20 0.53
AXL P30530 2/20 0.47
POLB P06746 1/20 0.46
DYRK1A Q13627 6/20 0.46
GSK3B P49841 1/20 0.45
IDO1 P14902 1/20 0.37
DCLK1 O15075 1/20 0.37
PRKD3 O94806 1/20 0.37
MAP4K4 O95819 1/20 0.37
CHEK2 O96017 1/20 0.37
CSF1R P07333 1/20 0.37
FER P16591 1/20 0.37
CDK2 P24941 1/20 0.37
MARK3 P27448 1/20 0.37
FLT4 P35916 1/20 0.37
FLT3 P36888 1/20 0.37
MAPK9 P45984 1/20 0.37
CSNK1D P48730 1/20 0.37
CLK2 P49760 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11970617 1.00 PDPK1 (0.53) PDPK1JAK2AXLPOLBDYRK1A
SCHEMBL11388 0.81 PDPK1 (0.58) PDPK1JAK2AXLDYRK1AGSK3B
SCHEMBL13726913 0.81 AXL (0.47) PDPK1JAK2AXLPOLBGSK3B
SCHEMBL10131351 0.81 POLB (0.46) PDPK1JAK2POLBDYRK1A
SCHEMBL23087732 0.80 POLB (0.66) POLBPIM1PIM2PRMT5WDR77
SCHEMBL28661400 0.78 PDPK1 (0.58) PDPK1JAK2AXLDYRK1AGSK3B
SCHEMBL27983814 0.78 PDPK1 (0.58) PDPK1JAK2AXLDYRK1AGSK3B
SCHEMBL17113571 0.78 PDPK1 (0.62) PDPK1JAK2AXLDYRK1AGSK3B
SCHEMBL1595677 0.76 POLB (0.65) PDPK1POLBIDO1
SCHEMBL31491930 0.76 POLB (0.65) PDPK1POLBIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049994-A1 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF ONCOPIA THERAPEUTICS, INC. D/B/A SK LIFE SCIENCE LABS (US) 2025-03-06 WO disclosed